低身高对孕期糖尿病的影响
Joan Crane1, Phil Murphy2, Donnette O'Brien2
1Department of Obstetrics and Gynecology, Faculty of Medicine, Memorial University of Newfoundland, St. John's, NL, Canada. joan.crane@icloud.com.
Acta diabetologica
|July 5, 2025
概括
短的母亲身高是孕期糖尿病的独立预测因素,特别是在正常体重指数 (BMI) 的女性中. 这一发现强调了在妊娠糖尿病风险评估中考虑母亲身高的重要性.
科学领域:
- 产科和妇科 产科和妇科
- 生殖健康 生殖健康
- 内分泌学 在内分泌学.
背景情况:
- 孕期糖尿病 (GDM) 是怀孕的一个严重并发症.
- 母亲的特征,包括身高和体重指数 (BMI),可能会影响GDM风险.
- 在预测GDM时,母亲身高和BMI之间的相互作用需要进一步研究.
研究的目的:
- 调查母亲身高矮与患妊娠糖尿病的风险之间的关联.
- 检查这种关联是否因不同的身体质量指数 (BMI) 类而改变.
主要方法:
- 基于人口的回顾性队列研究.
- 包括2012-2019年在加拿大纽芬兰和拉布拉多的单独怀孕.
- 母亲身高的分层分为短 (<25%),平均 (25-75%) 和高 (>75%) 组.
- 多变量回归分析对混因素进行调整,按BMI类分层.
主要成果:
- 总共分析了15803例怀孕,其中GDM发病率为6.7%.
- 短的母亲身高是整体GDM的独立预测因素 (OR=1.20).
- 在正常的BMI个体中,母亲的矮身高显著增加了GDM风险 (OR=1.75),但在较高的BMI类别中没有观察到这种关联.
结论:
- 母亲身高矮对GDM风险的影响取决于母亲的BMI.
- 低身高的母亲是正常BMI的女性GDM的重要独立风险因素.
- 这些发现表明,针对GDM的个性化风险评估应考虑母亲的身高和BMI.
相关概念视频
Pathophysiology of Diabetes
1.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
1.2K
Diabetes Mellitus: Type 2 and Gestational
3.0K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.0K
Diabetes Mellitus: Overview and Type I Subtype
3.3K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.3K
Nature and Nurture
20.8K
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
20.8K
Diabetes: Symptoms, Diagnosis, and Complications
702
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
702
Oral Hypoglycemic Agents: Biguanides and Glitazones
309
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
309


